Exploring Targeted Therapies for Metastatic Lung Cancer

Exploration of treatment options including OSIMERTNIB, ALcFusions, and Ross1Fusion for metastatic non-small cell lung cancer, highlighting the importance of genetic mutation-based sequencing, ALc inhibitors, TKIs, and mnemonic devices for therapy selection while addressing potential adverse effects.